✦ LIBER ✦

Endpoints for homocysteine-lowering trials

✍ Scribed by Andrew G Bostom; Carol Garber

Book ID: 117312418
Publisher: The Lancet
Year: 2000
Tongue: English
Weight: 55 KB
Volume: 355
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(99)00437-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Homocysteine and vascular disease: revie

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials

✍ Robert Clarke; Jim Halsey; Derrick Bennett; Sarah Lewington 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 163 KB

Lowering homocysteine for stroke prevent

Lowering homocysteine for stroke prevention

✍ Cynthia M Carlsson 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 41 KB

A Controlled Trial of Homocysteine Lower

A Controlled Trial of Homocysteine Lowering and Cognitive Performance

✍ McMahon, Jennifer A.; Green, Timothy J.; Skeaff, C. Murray; Knight, Robert G.; M 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 209 KB

Surrogates for Fracture Endpoints in Cli

Surrogates for Fracture Endpoints in Clinical Trials

✍ Sundeep Khosla 📂 Article 📅 2003 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 87 KB

Economic analyses: New endpoints for cli

Economic analyses: New endpoints for clinical trials

✍ Andre Konski; Perry Grigsby 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Endpoints in Clinical Trials for Hepatoc

Endpoints in Clinical Trials for Hepatocellular Carcinoma

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 900 KB